MB "Fibroblastai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
13,600 |
13,600 |
3,245 |
3,082 |
3,082 |
-0.05 |
0.44 |
100.00 |
22.66 |
3,088 |
1,351 |
9,251 |
679 |
2022 |
---|
13,600 |
10,968 |
1,781 |
1,689 |
1,362 |
0.35 |
0.17 |
100.00 |
12.42 |
4,777 |
835 |
6,252 |
5,612 |
2023 |
---|
22,350 |
11,175 |
1,428 |
1,356 |
678 |
0.27 |
0.10 |
99.93 |
6.07 |
6,133 |
598 |
3,254 |
6,731 |
Register and
explore Okredo data2023 |
---|
22,350 |
11,175 |
1,428 |
1,356 |
678 |
0.27 |
0.10 |
99.93 |
6.07 |
6,133 |
598 |
3,254 |
6,731 |
Register and
explore Okredo data2023
Turnover (€)
22,350 €64 % *
Sales per employee (€)
11,175 €2 % *
Profit before tax (€)
1,428 €-20 % *
Net Profit (€)
1,356 €-20 % *
Profit per employee (€)
678 €-50 % *
Working capital requirement
0.27 -22.86 % *
Debt-to-equity ratio
0.10 -41.18 % *
Total profitability (%)
99.93 %-0.07 % *
Net profitability (%)
6.07 %-51.13 % *
Equity (€)
6,133 €28 % *
Amounts Payable And Liabilities (€)
598 €-28 % *
Non-current Assets (€)
3,254 €-48 % *
CurrentAssets (€)
6,731 €20 % *